[2-year experiences with the use of Gerlach's micromycete vaccine in inoperable cancer patients].
D006801:Humans; D016233:Immunotherapy, Active; D009369:Neoplasms; D014612:Vaccines
D014612:Vaccines
NEOPLASMS; VACCINE THERAPY